Skip to main content
TipRanks
Go Ultimate75% OFF

Janne Lt Wissel Insider Profile

4 Followers

Janne Lt Wissel, SVP, Chief Regulatory Officer at Jazz Pharmaceuticals, holds 48.54K shares in Jazz Pharmaceuticals (Ticker: JAZZ).

Janne Lt Wissel's Trading History

JAZZ
Jazz Pharmaceuticals
Jun 01, 2011SVP, Chief Regulatory OfficerUninformative Buy1.12K$11.64M
JAZZ
Insider Shares: 48.54K (0.08%)
DateTransactionAmountNo. of SharesPrice per ShareProfitLink to Report
Jun 01, 2011Uninformative Buy$1.12K1,323$0.85―
Dec 08, 2010Informative Sell$1.10M60,000$18.38-97.90%
Dec 02, 2010Uninformative Buy$1.18K1,391$0.85―
Nov 19, 2010Informative Sell$702.28K46,663$15.05-122.00%
Jun 01, 2010Uninformative Buy$1.21K1,428$0.85―

You May Also Like

Janne Lt Wissel insider profile FAQ

What is the percentage of profitable transactions made by Janne Lt Wissel?
The percentage of profitable transactions made by Janne Lt Wissel is 0%.
What is the average return per transaction made by Janne Lt Wissel?
The average return per transaction made by Janne Lt Wissel is -109.90%.
What stocks does Janne Lt Wissel hold?
Janne Lt Wissel holds: JAZZ stocks.
What was Janne Lt Wissel’s latest transaction?
Janne Lt Wissel’s latest transaction was an Uninformative Buy of $1.12K.
What was Janne Lt Wissel's most profitable transaction?
Janne Lt Wissel’s most profitable transaction was an Informative Sell of JAZZ stock on December 8, 2010. The return on the trade was -97.90%.
What is Janne Lt Wissel's role in Jazz Pharmaceuticals?
Janne Lt Wissel's role in Jazz Pharmaceuticals is SVP, Chief Regulatory Officer.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.

TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.